# OnCo record hct-conditioning-and-engraftment-care (protocol). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/protocols/hct-conditioning-and-engraftment-care/>
  a schema:MedicalGuideline ;
  onco:kind "protocol" ;
  schema:identifier "hct-conditioning-and-engraftment-care" ;
  schema:name "Stem cell transplant: conditioning, the low blood count phase and engraftment monitoring"@en ;
  schema:alternateName "haematopoietic cell transplant conditioning"@en, "HCT conditioning"@en, "HSCT conditioning"@en, "bone marrow transplant conditioning"@en, "preparative regimen"@en, "engraftment monitoring"@en, "neutrophil engraftment"@en, "platelet engraftment"@en, "graft failure"@en, "chimerism testing"@en, "engraftment syndrome"@en, "neutropenic phase after transplant"@en ;
  schema:description "Before a stem cell transplant you have conditioning: chemotherapy, sometimes with radiotherapy, usually over 1 to 10 days. It destroys unhealthy blood cells and holds back the immune system so the new cells can settle. For some weeks the blood counts are very low, so the team guards against infection, gives transfusions and checks the blood often until the new cells start working (engraftment)."@en ;
  schema:url <https://onco.cc/protocols/hct-conditioning-and-engraftment-care/> ;
  schema:dateModified "2026-11-17"^^xsd:date ;
  onco:related <https://onco.cc/protocols/allo-hct-gvhd-prophylaxis/>, <https://onco.cc/protocols/hepatic-veno-occlusive-disease-after-transplant/>, <https://onco.cc/protocols/stem-cell-mobilisation-and-collection/>, <https://onco.cc/protocols/febrile-neutropenia-first-hour/>, <https://onco.cc/protocols/antibacterial-prophylaxis-in-neutropenia/>, <https://onco.cc/protocols/antifungal-prophylaxis-in-haematology/>, <https://onco.cc/protocols/herpes-simplex-and-zoster-antiviral-prophylaxis/>, <https://onco.cc/protocols/pneumocystis-pneumonia-prophylaxis/>, <https://onco.cc/protocols/red-cell-and-platelet-transfusion-thresholds/>, <https://onco.cc/protocols/oral-mucositis-prevention-and-oral-care/>, <https://onco.cc/protocols/food-safety-and-neutropenic-diet/>, <https://onco.cc/protocols/neutropenic-precautions-and-daily-life/>, <https://onco.cc/protocols/vaccination-around-cancer-treatment/>, <https://onco.cc/protocols/car-t-lymphodepletion/>, <https://onco.cc/drugs/filgrastim/>, <https://onco.cc/drugs/melphalan/>, <https://onco.cc/drugs/treosulfan/>, <https://onco.cc/drugs/thiotepa/>, <https://onco.cc/drugs/fludarabine/> ;
  onco:technologies <https://onco.cc/technologies/allogeneic-hsct/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/technologies/total-body-irradiation/> ;
  onco:drugs <https://onco.cc/drugs/busulfan/> ;
  onco:terms <https://onco.cc/terms/conditioning-regimen/>, <https://onco.cc/terms/neutropenia/>, <https://onco.cc/terms/gvhd/> .
